GlucoBoost - Glucose Gel - Pack of 3

Product Information

Solutions containing glucose should be used with caution, if at all, in patients with known allergy to corn or corn products. When Glucose 40% w/v is used in conjunction with amino acids, the rate of administration of glucose should not exceed 1g/kg/hour for optimal protein anabolism. Unless appropriately diluted infusion of hypertonic glucose solutions into a peripheral vein may result in vein irritation, vein damage, and thrombosis. Strongly hypertonic solutions should only be administered through an indwelling intravenous catheter with the tip located in a large vein such as the superior vena cava.

Snap the lid off the tube of gel and squeeze gel into the child’s lower cheek whilst at the same time gently but firmly massaging the outside of the cheek. It is this action that stimulates partial absorption of the Glucogel. DO NOT place gel on your own finger to rub inside your child’s mouth. Once blood glucose level if 4mmol/l or above given 10-15g of slow acting carbohydrate (or their normal meal if it is a mealtime) to maintain the blood glucose level Clinical evaluation and periodic laboratory determinations may be necessary to monitor changes in fluid balance, electrolyte concentrations, and acid-base balance during prolonged parenteral therapy or whenever the condition of the patient or the rate of administration warrants such evaluation.

GlucoBoost Glucose Gel - 3 x 25g

If the blood glucose level is still 3.9mmol/l or below when you re-test repeat administration of Glucogel and re-test in another 15 minutes. The occurrence of septic complications can be decreased with heightened emphasis on aseptic technique in catheter placement, maintenance, as well as aseptic technique in nutritional formula preparation. Infection and sepsis may occur as a result of the use of intravenous catheters to administer parenteral formulations, poor maintenance of catheters or contaminated solutions.

GlucoBoost Glucose Gel from Ennogen Healthcare is a 40% Glucose Oral Gel that is widely used in the NHS. The product should be inspected visually for particulate matter and discoloration after admixing and prior to administration. Do not administer unless the solution is clear and the seal is intact. Refeeding severely undernourished patients may result in the refeeding syndrome that is characterized by the shift of potassium, phosphorus, and magnesium intracellularly as the patient becomes anabolic. Thiamine deficiency and fluid retention may also develop. Careful monitoring and slowly increasing nutrient intakes while avoiding overfeeding can prevent these complications. Careful symptomatic and laboratory monitoring for fever/chills, leukocytosis, technical complications with the access device, and hyperglycaemia can help recognize early infections.Identify all late preterm babies at birth and commence a hypoglycaemia/NEWS monitoring chart in labour ward. All babies should be risk assessed for criteria for hypoglycaemia monitoring and/or NEWS monitoring prior to leaving a labour ward environment

If the baby has an ongoing requirement of ≥120 ml/kg/day of milk / 10% glucose to maintain normoglycaemia, refer to the guideline for refractory hypoglycaemia Hypoglycaemia in the newborn can cause prolonged seizures, coma and brain damage. Hyperglycaemia has been associated with intraventricular haemorrhage, late onset bacterial and fungal infection, retinopathy of prematurity, necrotizing enterocolitits, bronchopulmonary dysplasia, prolonged length of hospital stay, and death.A late preterm infant who is at risk of hypoglycaemia should be screened with regular monitoring of the capillary glucose concentrations. Do not use plastic containers in series connections. Such use could result in air embolism due to residual air being drawn from the primary container before the administration of the fluid from the secondary container is completed. thiamine deficiency, e.g., in patients with chronic alcoholism (risk of severe lactic acidosis due to impaired oxidative metabolisation of pyruvate),

The infusion rate and volume depends on the age, weight, clinical and metabolic conditions of the patient, concomitant therapy, and should be determined by a consulting physician experienced in paediatric intravenous fluid therapy. Pulmonary vascular precipitates have been reported in patients receiving parenteral nutrition. In some cases, fatal outcomes have occurred. Excessive addition of calcium and phosphate increases the risk of the formation of calcium phosphate precipitates. Precipitates have been reported even in the absence of phosphate salt in the solution. Glucose solution (an aqueous, i.e., electrolyte-free glucose solution) should not be administered through the same equipment as whole blood, as haemolysis and pseudoagglutination can occur. Discontinue monitoring when blood glucose concentrations have been > 2.5mmol/l on three consecutive occasions at least 3 hours apart. Observe feeding in hospital for at least a further 24 hours ensuring it is effective while remaining vigilant for the signs of hypoglycaemia. If signs of hypoglycaemia develop or there are concerns about feeding discuss with medical staff and consider taking a further blood glucose. Not for direct intravenous infusion. Must be appropriately diluted before use. The admixture obtained should be administered through a central or peripheral venous line depending on its final osmolarity.

Brand

Hepatic failure, Hepatic cirrhosis, Hepatic fibrosis, Cholestasis, Hepatic steatosis, Blood bilirubin increased, Hepatic enzyme increased, Cholecystitis, Cholelithiasis